{
  "id": "9386cc2d5e1c52fc",
  "title": "Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia\u00ae and XGEVA\u00ae",
  "description": "20251222T223000Z",
  "content": "",
  "source": "manilatimes.net",
  "source_url": "https://www.manilatimes.net/2025/12/23/tmt-newswire/globenewswire/amneal-announces-fda-approval-of-denosumab-biosimilars-referencing-prolia-and-xgeva/2248352",
  "published_at": "20251222T223000Z",
  "fetched_at": "2025-12-23T00:22:44.609575+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda"
  ],
  "location": "Philippines",
  "raw_data": {
    "url": "https://www.manilatimes.net/2025/12/23/tmt-newswire/globenewswire/amneal-announces-fda-approval-of-denosumab-biosimilars-referencing-prolia-and-xgeva/2248352",
    "url_mobile": "https://www.manilatimes.net/2025/12/23/tmt-newswire/globenewswire/amneal-announces-fda-approval-of-denosumab-biosimilars-referencing-prolia-and-xgeva/2248352/amp",
    "title": "Amneal Announces FDA Approval of Denosumab Biosimilars Referencing Prolia\u00ae and XGEVA\u00ae",
    "seendate": "20251222T223000Z",
    "socialimage": "https://www.manilatimes.net/manilatimes/uploads/images/2025/12/23/877516.png",
    "domain": "manilatimes.net",
    "language": "English",
    "sourcecountry": "Philippines"
  }
}